SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-014884
Filing Date
2023-02-27
Accepted
2023-02-27 17:05:39
Documents
14
Period of Report
2023-02-23
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea174308-8k_oramed.htm   iXBRL 8-K 29002
2 FOURTH AMENDED AND RESTATED BY-LAWS, ADOPTED EFFECTIVE FEBRUARY 23, 2023 ea174308ex3-1_oramed.htm EX-3.1 123981
3 FOURTH AMENDED AND RESTATED BY-LAWS, ADOPTED EFFECTIVE FEBRUARY 23, 2023 (MARKED ea174308ex3-2_oramed.htm EX-3.2 148096
  Complete submission text file 0001213900-23-014884.txt   536293

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ormp-20230223.xsd EX-101.SCH 3221
5 XBRL LABEL FILE ormp-20230223_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE ormp-20230223_pre.xml EX-101.PRE 22355
8 EXTRACTED XBRL INSTANCE DOCUMENT ea174308-8k_oramed_htm.xml XML 3721
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35813 | Film No.: 23676393
SIC: 2834 Pharmaceutical Preparations